Last Updated: June 24, 2026

Details for New Drug Application (NDA): 020675

✉ Email this page to a colleague

NDA 020675 describes URSO FORTE, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. Additional details are available on the URSO FORTE profile page.

The generic ingredient in URSO FORTE is ursodiol. There are eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

Summary for 020675

Tradename:	URSO FORTE
Applicant:	Abbvie
Ingredient:	ursodiol
Patents:	0

Pharmacology for NDA: 020675

Suppliers and Packaging for NDA: 020675

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
URSO 250	ursodiol	TABLET;ORAL	020675	NDA	Allergan, Inc.	58914-785	58914-785-10	100 TABLET, FILM COATED in 1 BOTTLE (58914-785-10)
URSO 250	ursodiol	TABLET;ORAL	020675	NDA	Allergan, Inc.	58914-790	58914-790-01	4 TABLET, FILM COATED in 1 BLISTER PACK (58914-790-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Dec 10, 1997	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	500MG
Approval Date:	Jul 21, 2004	TE:		RLD:	Yes

Expired US Patents for NDA 020675

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	URSO 250	ursodiol	TABLET;ORAL	020675-001	Dec 10, 1997	⤷ Start Trial	⤷ Start Trial
Abbvie	URSO FORTE	ursodiol	TABLET;ORAL	020675-002	Jul 21, 2004	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.